Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.3 (
topoisomerase
)
9,911
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Here, we report that an E-box element located within the human
topoisomerase
III alpha (hTOP3 alpha) gene promoter acts as a cell type-specific enhancer. The upstream stimulatory factor (USF) was shown to specifically recognize the mutationally sensitive E-box element. When assayed by transient transfection with hTOP3 alpha promoter-dependent reporter genes, USF is transcriptionally active in HeLa cells but lacks transcriptional activity in Saos-2 cells. The hTOP3 alpha mRNA level in Saos-2 cells was reduced to about 30% of the level observed for HeLa cells, suggesting that the inactivity of USF in hTOP3 alpha promoter activity may be the cause of the marked reduction of hTOP3 alpha mRNA levels in Saos-2 cells. Using transient transfection assays in HeLa cells, we demonstrated that ectopically expressed
USF2
, but not USF1, was capable of activating hTOP3 alpha transcription through the E-box element. However,
USF2
did not stimulate hTOP3 alpha promoter activity in Saos-2 cells. This cell type-specific regulation of promoter activity by
USF2
may provide a mechanism for the differential expression of hTOP3 alpha in various tissues and during developmental stages.
...
PMID:Cell type-dependent regulation of human DNA topoisomerase III alpha gene expression by upstream stimulatory factor 2. 1155 42